Neurocrine Biosciences, Inc. (NBIX): Price and Financial Metrics
Neurocrine Biosciences, Inc. (NBIX)
Today's Latest Price: $99.01 USD
Updated Oct 23 4:00pm
Add NBIX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
NBIX Stock Summary
- NBIX's price/sales ratio is 8.89; that's higher than the P/S ratio of 84.94% of US stocks.
- Over the past twelve months, NBIX has reported earnings growth of 400.63%, putting it ahead of 96.16% of US stocks in our set.
- As for revenue growth, note that NBIX's revenue has grown 66.15% over the past 12 months; that beats the revenue growth of 92.09% of US companies in our set.
- Stocks that are quantitatively similar to NBIX, based on their financial statements, market capitalization, and price volatility, are RP, FLGT, APPS, FORM, and MASI.
- Visit NBIX's SEC page to see the company's official filings. To visit the company's web site, go to www.neurocrine.com.
NBIX Stock Price Chart Interactive Chart >
NBIX Price/Volume Stats
| Current price | $99.01 | 52-week high | $136.26 |
| Prev. close | $96.53 | 52-week low | $72.14 |
| Day low | $96.38 | Volume | 502,900 |
| Day high | $99.16 | Avg. volume | 822,011 |
| 50-day MA | $104.71 | Dividend yield | N/A |
| 200-day MA | $107.32 | Market Cap | 9.23B |
Neurocrine Biosciences, Inc. (NBIX) Company Bio
Neurocrine Biosciences discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company was founded in 1992 and is based in San Diego, California.
Loading social stream, please wait...